期刊文献+

益气活血平肝汤治疗高血压肾病患者临床疗效及血同型半胱胺酸影响 被引量:5

Therapeutic Effect of Yiqi Huoxue Pinggan Decoction for Hypertension Nephropathy and Its Influence on Blood Cysteamine Acid
下载PDF
导出
摘要 目的:观察中药益气活血平肝汤结合常规西药对高血压肾病(HN)患者的临床疗效及血同型半胱胺酸(tHcy)的影响。方法:选择?HN患者100例进行前瞻性随机对照临床试验。治疗组和对照组各50例,治疗组给予西药常规治疗基础上加益气活血平肝汤加减治疗,对照组用西药常规治疗,疗程均为2个月。观察患者临床疗效,并检测治疗前和治疗2个月后血同型半胱胺酸含量、24?h尿蛋白定量、血肌酐、尿素氮水平。结果:总有效率治疗组76%,对照组52%,两组比较,差异有显著性意义(P<0.05)?;治疗两组血同型半胱胺酸(tHcy)含量分别与治疗前比较,差异均有显著性意义(P<0.05),两组治疗后24?h尿蛋白定量、血肌酐、尿素氮比较,差异均有显著性意义(P<0.05)。结论:益气活血平肝汤结合常规西药能有效改善HN的临床症状,降低血同型半胱胺酸含量,降低24?h尿蛋白定量、血肌酐、尿素氮水平。 Objective : To observe the effect of Yiqi Huoxue Pinggan Decoction combined conventional Western medicine and its influence on blood cysteamine acid level in hypertension nephropathy ( HN ). Methods : A prospective, randomize-controlled trial was conducted. One hundred HN patients were equally randomized into two groups. The treatment group received Yiqi Huoxue Pinggan Decoction with Western medicine and the control group was treated with conventional Western medicine. The course of treatment lasted 2 months. The clinical effects were observed and level of blood cysteamine acid, 24 hours urine protein, urea nitrogen ( BUN ) and serum creatinine ( Scr ) were detected before and after treatment. After treatment, the clinical effect was evaluated. Results : The total effective rate was 76% in the treatment group, and was 52% in the control group, and the difference was significant ( P〈0.05 ). Blood cysteamine acid level in both groups after treatment differed from that before treatment ( P〈0.05 ). 24 hours urine protein, BUN and Scr in both groups after treatment differed from that before treatment ( P〈0.05 ). Conclusion : Yiqi Huoxue Pinggan Decoction combined conventional Western medicine is effective on relieving clinical symptoms and reducing the expression of blood cysteamine acid, 24 hours urine protein, urea nitrogen( BUN ) and serum creatinine ( Scr ) in HN patients.
出处 《辽宁中医药大学学报》 CAS 2014年第4期5-7,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 广西壮族自治区卫生厅重点科研课题(重200714)
关键词 高血压肾病 中西医结合疗法 益气活血平肝汤 血同型半胱胺酸 hypertension nephropathy combined treatment of traditional Chinese and Westernmedicine Yiqi Huoxue Pinggan Decoction blood cysteamine acid
  • 相关文献

参考文献7

二级参考文献49

  • 1郑敏,杨宏杰,张丹,陈咸川.黄芪提取液清除自由基的实验研究[J].山东中医杂志,2004,23(12):743-745. 被引量:43
  • 2杨凤华,张文竹,康成,张德山.黄芪水溶性黄酮类对小鼠T淋巴细胞及其亚群影响的量效关系研究[J].中国新医药,2003,2(4):10-12. 被引量:12
  • 3谷元武.黄芪注射液的临床应用[J].现代中西医结合杂志,2005,14(18):2482-2483. 被引量:13
  • 4赵莲芳,郑玉淑,朴惠顺,张善玉.黄芪多糖及人参总皂苷对衰老小鼠的抗衰老作用[J].延边大学医学学报,2006,29(4):249-251. 被引量:54
  • 5张群豪 陈可冀.血清药理学在中药及复方研究中应用的评价[J].中国中西医结合杂志,1996,16(3):131-131.
  • 6Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int, 1999,56(5):1627 - 1637.
  • 7Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2000,414 (6865) : 813 - 820.
  • 8Ichimura T,Asseldonk EJ, Humphreys BD, et al. Kidney injury molecule- 1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest, 2008,118 (5) : 1657 - 1668.
  • 9Lee HB, Ha H. Piasminogen activator inhibitor - 1 and diabetic nephropathy. Nephrology, 2005,10 (Suppl) : S11 - S13.
  • 10Eddy AA, Fogo AB. Plasminogen activator inhibitor - 1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol,2006,17(11) :2999 - 3012.

共引文献514

同被引文献51

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部